June 17, 2024
- A recent research article is one of the first studies to investigate the relationship between autistic symptoms and somatic problems in adults from the general population. The study found that autistic symptoms were associated with conditions such as irritable bowel syndrome (IBS), food allergies, pain, and fatigue. The article also identified sex differences, with stronger associations between autistic symptoms and pain and fatigue in females. Additionally, younger adults showed stronger links to fatigue and food allergies, while older adults had higher risks of IBS and pain if they had probable autism. These findings suggest the need for routine screening, assessment, and tailored interventions for autism-related somatic problems, emphasizing specific attention to different age groups and sexes to improve health outcomes for individuals on the spectrum.
- Stephanie Seneff has co-authored a new study that investigates the dramatic rise in autism incidence over the past two decades, suggesting that its causes are multifaceted, involving toxicants, genetics, and nutrient deficiencies. The work primarily focuses on glyphosate exposure as a significant environmental factor contributing to autism. The authors provide substantial evidence linking glyphosate exposure to the biochemical and histological pathologies observed in individuals with autism and explain how glyphosate suppresses melatonin production, which generally helps protect against these pathologies. A key finding is that glyphosate and other factors suppress the activity of cellular isomerase PIN1, triggering a cascade of events that lead to autism-related neurological issues. The study underscores the critical role of PIN1 in cellular regulatory pathways. It highlights the increased vulnerability of infants and children to these pathological changes, emphasizing the need for further research and potential intervention strategies.
- New commentary from the CDC’s Autism and Developmental Disabilities Monitoring Network reveals that Black youth with autism now account for approximately 30% of the latest 1 in 36 autism prevalence rate, reducing the diagnosis disparity between Black and White youth. The research found that Black, Hispanic/Latine, and Asian/Pacific Islander children are identified with autism at higher rates by age 4 compared to White children. However, Black girls on the spectrum are still diagnosed later and more frequently with co-occurring intellectual disabilities. Despite the narrowed identification gap, significant disparities remain in the quality of life, access to services, and post-high school outcomes for Black youth with autism. This work underscores the need for improved diagnostic practices, increased funding for under-resourced communities, and culturally responsive care to better support Black individuals on the spectrum throughout their lives.
- Openings are available for a treatment study on Microbiota Transplant Therapy for children with ASD and gastrointestinal disorders. The study, led by James Adams, Ph.D., aims to reduce chronic gastrointestinal issues and improve autism-related symptoms in children with ASD aged 4 to under 18 years who suffer from chronic constipation, diarrhea, or similar gut problems. The treatment involves 14 days of a special antibiotic, a one-day bowel cleanse, and 13 weeks of purified microbiota mixed with milk or yogurt (including dairy-free options) accompanied by an antacid. This placebo-controlled study has two parts: in Part 1, half of the participants receive the treatment while the other half receive a placebo. In Part 2, the placebo group switches to the actual treatment. Each part lasts approximately 15 weeks, with follow-up evaluations at 15 weeks after treatment. No travel to ASU is required.
